Taxanes in hormone-refractory prostate cancer

被引：8
|
作者：
Kang, MH [1 ]
Figg, WD [1 ]
Dahut, W [1 ]
机构：
[1] NCI, Med Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA
来源：
CANCER PRACTICE | 1999年 / 7卷 / 05期
关键词：
D O I：
10.1046/j.1523-5394.1999.75005.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：270 / 272
页数：3
相关论文
共 50 条
  • [1] Taxanes in the chemotherapy of hormone-refractory prostate
    Johannsen, M
    Wilke, K
    Schnorr, D
    Loening, SA
    UROLOGE A, 2004, 43 (02): : 160 - 167
  • [2] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [3] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [4] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [5] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    TUMORI, 2003, : S147 - S149
  • [6] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [7] Satraplatin for hormone-refractory prostate cancer
    Kerr, Cathel
    LANCET ONCOLOGY, 2007, 8 (04): : 290 - 290
  • [8] Chemotherapy for hormone-refractory prostate cancer
    Shelley, Mike
    Harrison, Craig
    Coles, Bernadette
    Staffurth, John
    Wilt, Timothy J.
    Mason, Malcolm D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [9] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [10] Therapy of hormone-refractory prostate cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4796 - 4796
12345